Home Cart 0 Sign in  

[ CAS No. 77449-94-6 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 77449-94-6
Chemical Structure| 77449-94-6
Structure of 77449-94-6 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 77449-94-6 ]

Related Doc. of [ 77449-94-6 ]

Alternatived Products of [ 77449-94-6 ]

Product Details of [ 77449-94-6 ]

CAS No. :77449-94-6 MDL No. :MFCD09749867
Formula : C5H10ClNO3 Boiling Point : -
Linear Structure Formula :- InChI Key :YEJFFQAGTXBSTI-VKKIDBQXSA-N
M.W : 167.59 Pubchem ID :12310682
Synonyms :

Calculated chemistry of [ 77449-94-6 ]

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.8
Num. rotatable bonds : 1
Num. H-bond acceptors : 4.0
Num. H-bond donors : 3.0
Molar Refractivity : 40.65
TPSA : 69.56 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -9.01 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.0
Log Po/w (XLOGP3) : -2.37
Log Po/w (WLOGP) : -0.78
Log Po/w (MLOGP) : -3.07
Log Po/w (SILICOS-IT) : -0.67
Consensus Log Po/w : -1.38

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : 0.68
Solubility : 802.0 mg/ml ; 4.79 mol/l
Class : Highly soluble
Log S (Ali) : 1.45
Solubility : 4700.0 mg/ml ; 28.0 mol/l
Class : Highly soluble
Log S (SILICOS-IT) : 0.66
Solubility : 763.0 mg/ml ; 4.55 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.31

Safety of [ 77449-94-6 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 77449-94-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 77449-94-6 ]
  • Downstream synthetic route of [ 77449-94-6 ]

[ 77449-94-6 ] Synthesis Path-Upstream   1~7

  • 1
  • [ 51-35-4 ]
  • [ 77449-94-6 ]
YieldReaction ConditionsOperation in experiment
90%
Stage #1: for 6 h; Reflux
Stage #2: With hydrogenchloride In water for 3 h; Reflux
A mixture of (2S,4R)-4-hydroxypyrrolidine-2-carboxylicacid(50 mmol, 6550 mg) and Ac2O (250 mmol, 23.5 mL) in AcOH (100 mL) wasstirred at reflux for 6 h. The resulting mixture was concentrated to give thecrude intermediate. The solution of this crude intermediate in 2 N HCl (50 mL)was stirred at reflux for 3 h. Then activated charcoal (1 g) was added, the hotmixture was ltered immediately through a Celite layer. The filtrate was concentrated in vacuo to give the crude intermediate.The crude intermediate was dissolved in acetone and filtered. The residue was washed twice with ether anddried in vacuo to give 17 as a white solid (7.54 g, 90percent). 1H NMR (400 MHz, D2O) δ 4.57-4.37(m, 2H), 3.42-3.21 (m, 2H), 2.46-2.31 (m, 1H), 2.31-2.20 (m, 1H). 13C NMR (100 MHz, D2O) δ 172.3, 68.9, 58.4, 53.3, 36.8.
75%
Stage #1: at 50 - 90℃; for 5.5 h;
Stage #2: for 3 h; Heating / reflux
PREPARATION 25
(2R,4R)-4-Hydroxy-pyrrolidine-2-carboxylic acid, hydrochloride
To a mixture of acetic anhydride (408 g) and acetic acid (1.2 L) at 50° C. add trans-4-hydroxy-L-proline (0.36 mol, 94 g) in a single portion.
Heat the reaction mixture for 5.5 h at 90° C. and then concentrate it.
Dissolve the residue in 2 N hydrochloric acid and reflux for 3 h.
Cool the reaction mixture to room temperature, filter through diatomaceous earth, and concentrate under vacuum until white needles form.
Filter the crystals, wash with ether, and dry under vacuum to obtain the title compound (90.0 g, 75percent).
[α]D20+10.0 (c=1.0 in methanol).
1H NMR (400 MHz, D2O), δ 2.34-2.39 (m, 1H), 2.45-2.53 (m, 1H), 3.38 (dd, 1H), 3.45 (d, 1H), 4.50 (dd, 1H), 4.58 (br s, 1H).
65%
Stage #1: With acetic anhydride In acetic acid at 20 - 90℃;
Stage #2: With hydrogenchloride In water for 3 h; Reflux
Following a procedure essentially as described in Tetrahedron: Asymmetry, 14, (2003) 3141-3152, to a mixture of acetic anhydride (1.437 kg, 5.65 eq) and acetic acid (4.225 L) at 500C add ?raws-4-hydroxy-L-proline (331 g, 2.49 mol) in portions over 30 min. Heat the reaction mixture for 5.5 h at 90 0C then allow to cool to room temperature. Stir the reaction at room temperature overnight and then concentrate. Dissolve the residue in 2 N hydrochloric acid (4.57 L) and reflux for 3 h. Cool the reaction mixture to room temperature, filter through diatomaceous earth, and concentrate under vacuum at 70 0C to approximately 700 mL. Allow the material to cool to room temperature and let sit overnight. Dilute the resulting slurry with ether (IL), filter the crystals, wash with ether, and dry under vacuum to obtain the title compound (340 g). Dissolve the solid in hot ethanol (2.5 L), cool, stir slowly at 35 0C, and add ether (2.5 L) slowly in portions over one hour. Stir for 2 h, filter the resulting white solid, and dry overnight in a vacuum oven to obtain the title compound (270.6 g, 65percent). [α]D20 + 12.0 (c = 1.0 in methanol). 1H NMR (400 MHz, D2O), δ 2.34-2.39 (m, IH), 2.45-2.53 (m, IH), 3.38 (dd, IH), 3.45 (d, IH), 4.50 (dd, IH), 4.58 (br s, IH).
Reference: [1] Journal of Organic Chemistry, 2009, vol. 74, # 2, p. 513 - 519
[2] Bioorganic and Medicinal Chemistry Letters, 2016, vol. 26, # 10, p. 2434 - 2437
[3] Journal of the American Chemical Society, 2013, vol. 135, # 11, p. 4333 - 4363
[4] Patent: US2009/163472, 2009, A1, . Location in patent: Page/Page column 21
[5] Journal of Heterocyclic Chemistry, 2011, vol. 48, # 5, p. 1132 - 1139
[6] Journal of Organic Chemistry, 2010, vol. 75, # 5, p. 1620 - 1629
[7] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 15, p. 4099 - 4101
[8] Patent: WO2010/104721, 2010, A1, . Location in patent: Page/Page column 21
[9] Journal of Organic Chemistry, 1981, vol. 46, # 14, p. 2954 - 2960
[10] Journal of Organic Chemistry, 1994, vol. 59, # 13, p. 3616 - 3625
[11] Journal of the Chemical Society - Perkin Transactions 1, 1997, # 4, p. 539 - 546
[12] Patent: WO2014/32, 2014, A1,
  • 2
  • [ 444313-67-1 ]
  • [ 77449-94-6 ]
Reference: [1] Patent: WO2014/32, 2014, A1, . Location in patent: Page/Page column 64
  • 3
  • [ 13726-69-7 ]
  • [ 77449-94-6 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2009, vol. 19, # 1, p. 21 - 26
  • 4
  • [ 24424-99-5 ]
  • [ 77449-94-6 ]
  • [ 135042-12-5 ]
YieldReaction ConditionsOperation in experiment
78% With sodium hydroxide In tetrahydrofuran; water at 20℃; cis-4-Hydroxy-l-proline hydrochloride 14 (0.50 g, 3.0 mmol) was dissolved in 6 mL of THF/H2O (2:1) and then treated with 10percent aqueous NaOH (1.25 mL) followed by the addition of di-tert-butyldicarbonate (0.95 g, 4.42 mmol).
The reaction mixture was stirred at room temperature overnight and then THF was removed by rotavapor.
The residue was adjusted to pH 2 by the addition of 10percent aqueous KHSO4.
The acidic solution was extracted several times with ethyl acetate.
The combined organic extracts were washed with H2O and brine, and dried over anhydrous Na2SO4.
The solvent was removed by a rotary evaporator to afford compound 15 as a syrup (542 mg, 78percent), which was used without purification for the next step. [α]D25 = 15.3 (c 1.02, MeOH). IR (film): ν = 3462, 2976, 2934, 1740, 1639 cm-1. 1H NMR (400 MHz, CDCl3) δ 7.22 (br s, 1H), 5.11-5.09 (m, 2H), 4.94-4.93 (m, 1H), 4.40 (s, 1H), 3.64-3.62 (m, 1H), 3.49-3.44 (m, 2H), 2.27-1.90 (s, 9H).
13C NMR (100 MHz, CDCl3): δ 172.47, 151.74, 75.81, 67.15, 55.24, 52.27, 35.97, 25.63 ppm. HRMS (ESI): m/z [M+H]+ calcd for C10H18NO5: 232.1185; found: 232.1171.
70.1% With sodium hydroxide In tetrahydrofuran; water at 20℃; At room temperature,A solution of sodium hydroxide (4.73 g, 118.14 mmol) in water (41 mL) was added dropwise to a solution of 3A (9.0 g, 53.70 mmol) in tetrahydrofuran (90 mL)A mixture of di-tricarbonate (17.58 g, 80.55 mmol)Was added to the reaction solution, and the reaction was stirred at room temperature overnight.(2.15 g, 53.70 mmol), di-n-tri-n-butyl ester (9.38 g, 42.96 mmol) was added and stirring was continued at room temperature for 5 hours.Tetrahydrofuran was removed by distillation under reduced pressure, and the impurities were extracted with ethyl acetate (50 mL x 2).The aqueous phase was adjusted to pH 3 with 3 mol / L hydrochloric acid solution and extracted with ethyl acetate (50 mL x 3)The organic phases were combined, dried over anhydrous magnesium sulfate, filtered, and the filtrate was concentrated under reduced pressure to give colorless liquid 15a (8.7 g, yield 70.1percent).
Reference: [1] Journal of Medicinal Chemistry, 2018, vol. 61, # 3, p. 681 - 694
[2] Journal of the American Chemical Society, 2013, vol. 135, # 11, p. 4333 - 4363
[3] Tetrahedron Asymmetry, 2015, vol. 26, # 20, p. 1156 - 1166
[4] Patent: TW2017/8221, 2017, A, . Location in patent: Page/Page column 92; 93
  • 5
  • [ 67-56-1 ]
  • [ 77449-94-6 ]
  • [ 114676-59-4 ]
YieldReaction ConditionsOperation in experiment
100% at 0 - 75℃; for 4.5 h; Cis-4-hydroxy-D-proline hydrochloride 3A (12.8 g, 76.38 mmol) was dissolved in anhydrous methanol (120 mL) at room temperature,Cooled to 0 , dichloro sulfoxide (10.27g, 86.31mmol),Heated to 75 ° C, refluxed for 4.5 hours, and allowed to react overnight at room temperature.The solvent was taken off in vacuo to give a white solid 3B (13.83 g, yield 100percent).
Reference: [1] Patent: TW2017/8221, 2017, A, . Location in patent: Page/Page column 41
[2] Journal of Organic Chemistry, 2009, vol. 74, # 2, p. 513 - 519
[3] Patent: US2009/163472, 2009, A1, . Location in patent: Page/Page column 21
[4] Patent: WO2014/32, 2014, A1, . Location in patent: Page/Page column 64
[5] Bioorganic and Medicinal Chemistry Letters, 2016, vol. 26, # 10, p. 2434 - 2437
  • 6
  • [ 77449-94-6 ]
  • [ 155075-23-3 ]
Reference: [1] Patent: WO2014/32, 2014, A1,
  • 7
  • [ 77449-94-6 ]
  • [ 256487-77-1 ]
Reference: [1] Patent: TW2017/8221, 2017, A,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 77449-94-6 ]

Amino Acid Derivatives

Chemical Structure| 2584-71-6

[ 2584-71-6 ]

H-D-cis-Hyp-OH

Similarity: 0.98

Chemical Structure| 618-27-9

[ 618-27-9 ]

(2S,4S)-4-Hydroxypyrrolidine-2-carboxylic acid

Similarity: 0.98

Chemical Structure| 51-35-4

[ 51-35-4 ]

(2S,4R)-4-Hydroxypyrrolidine-2-carboxylic acid

Similarity: 0.98

Chemical Structure| 3398-22-9

[ 3398-22-9 ]

(2R,4S)-4-Hydroxypyrrolidine-2-carboxylic acid

Similarity: 0.98

Chemical Structure| 567-35-1

[ 567-35-1 ]

(2S,3R)-3-Hydroxypyrrolidine-2-carboxylic acid

Similarity: 0.93